![Katsuaki Maehara: The changes in TME and TKI treatment resistance by EGFR and ALK TKI](https://oncodaily.com/pub/uploads/2023/10/download-226-e1716291499657.jpg)
Photo from Katsuaki Maehara/X
Jun 29, 2024, 07:45
Katsuaki Maehara: The changes in TME and TKI treatment resistance by EGFR and ALK TKI
Katsuaki Maehara, Director of Medical Education Colleagues, shared a post on X: .
“A valuable paper that reveals the changes in tumor microenvironment (TME) and Tyrosine Kinase Inhibitor (TKI) treatment resistance by EGFR and ALK TKI, and studies on overcoming resistance with adjuvant therapies such as aspirin.”
Proceed to the paper.
Source: Katsuaki Maehara/X
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023